Publication

Article

The American Journal of Managed Care

May 2003
Volume9
Issue 5

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo